Hirotaka Mano
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Randomized Study of Antithrombin in Early-Onset Preeclampsia: KOUNO-TORI Study.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: March 06, 2026
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis.
Journal: Dermatology and therapy
Published: May 20, 2025
Adjusting confidence intervals under covariate-adaptive randomization in non-inferiority and equivalence trials.
Journal: Contemporary clinical trials
Published: December 13, 2024
Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab.
Journal: Archives of dermatological research
Published: August 15, 2024
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study.
Journal: Advances in therapy
Published: October 10, 2023
Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply.
Journal: Lancet (London, England)
Published: February 22, 2023
Application of sample size re-estimation in clinical trials: A systematic review.
Journal: Contemporary clinical trials communications
Published: February 16, 2023
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study.
Journal: Lancet (London, England)
Published: August 04, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026